This article was accepted into the corpus but its outbound wikilinks were never NER-processed — typical at the deepest BFS hop or when the run's entity cap was reached. No expansion funnel to show.
| streptomycin trial | |
|---|---|
| Name | Streptomycin trial |
| Date | 1946–1947 |
| Location | United Kingdom |
| Investigators | Medical Research Council, St Thomas' Hospital, Nuffield Department of Medicine |
| Intervention | Streptomycin |
| Condition | Tuberculosis |
streptomycin trial
The streptomycin trial was a landmark clinical study conducted in the United Kingdom in 1946–1947 that compared the antibiotic streptomycin with other treatments for pulmonary tuberculosis and helped establish randomized controlled trial methodology. The study involved institutions including the Medical Research Council, St Thomas' Hospital, and practitioners associated with Sir Austin Bradford Hill, and had substantial influence on postwar National Health Service policy and international World Health Organization recommendations. The trial's design, outcomes, and controversies intersected with figures and organizations across Oxford University, Cambridge University, Guy's Hospital, and governments in United States, India, and Canada.
The trial emerged from wartime and immediate postwar concerns about tuberculosis treatment, building on discoveries by scientists at institutions such as Rutgers University, Columbia University, London School of Hygiene & Tropical Medicine, and the pharmaceutical firm Squibb. Influential medical leaders including Franklin D. Roosevelt era health advisors, researchers at Harvard Medical School, and clinicians from Massachusetts General Hospital and Johns Hopkins Hospital followed developments in antibiotic therapy. Key proponents who shaped the environment for the trial included researchers connected to Alexander Fleming, investigators influenced by the Lasker Award community, and administrators from the Royal Society. The availability of streptomycin, synthesized and produced with inputs from companies like E. R. Squibb and Sons and distribution networks linked to UN Relief and Rehabilitation Administration, motivated the Medical Research Council to evaluate efficacy in a controlled setting at hospitals including St Thomas' Hospital and Guy's Hospital.
The trial applied methods developed by Austin Bradford Hill and colleagues drawing on earlier randomized experiments involving investigators at University of Oxford and statistical guidance from figures associated with London School of Hygiene & Tropical Medicine and University College London. Allocation procedures referenced techniques similar to those used in trials by investigators from Royal Army Medical Corps and statisticians who had collaborated with Winston Churchill's wartime scientific advisers. Eligibility criteria, enrollment at clinical centers such as St Thomas' Hospital and Guy's Hospital, and endpoint definitions were drafted with input from committees linked to the Medical Research Council and ethics deliberations among representatives from Royal College of Physicians, Royal College of Surgeons, and administrators tied to Ministry of Health. Outcomes included radiologic improvement assessed against standards developed at Mayo Clinic, bacteriologic conversion referencing methods used at Centers for Disease Control and Prevention precursor laboratories, and mortality comparable to metrics employed in studies at Bellevue Hospital and Toronto General Hospital.
Results reported improved clinical and radiographic responses among patients receiving streptomycin combined with bed rest when compared with contemporaneous regimens commonly practiced at institutions like King's College Hospital and Addenbrooke's Hospital. The trial documented bacteriological conversion rates and survival data contextualized by findings from contemporaneous research at Mount Sinai Hospital (New York City), Johns Hopkins Hospital, and University of Toronto. Publications and presentations involving contributors with affiliations to Oxford University, Cambridge University, University College Hospital, and international collaborators from United States Public Health Service disseminated the data, prompting commentaries in medical forums including The Lancet and proceedings of meetings of the Royal Society of Medicine.
The trial provoked ethical debates involving bodies such as the Royal College of Physicians, Nuremberg Trials-era discussions on human experimentation, and committees influenced by precedents set in inquiries at Truman administration health policy forums and by scholars associated with Yale University and Columbia University. Questions arose about informed consent practices relative to standards later codified in documents influenced by the Nuremberg Code and deliberated within organizations like the World Health Organization and Council for International Organizations of Medical Sciences. Legal implications touched on legislation considered in the House of Commons and analogues debated in the United States Congress and provincial legislatures in Ontario and Quebec, with professional regulation by entities such as the General Medical Council and hospital boards at St Thomas' Hospital and Guy's Hospital.
The trial shaped treatment paradigms at major centers including Royal Brompton Hospital, Mayo Clinic, Massachusetts General Hospital, and influenced policy at national agencies such as the National Health Service and the United States Public Health Service. Findings contributed to protocols endorsed by the World Health Organization and informed procurement decisions by bodies like UNICEF and national ministries modeled on the Ministry of Health. The methodological approaches helped standardize randomized designs adopted in trials at Harvard Medical School, Johns Hopkins School of Medicine, and University of Oxford, and influenced regulatory frameworks later enforced by agencies with roots in institutions such as Food and Drug Administration predecessors and advisory committees associated with the Medical Research Council.
Subsequent studies at centers including Stanford University School of Medicine, University of California, San Francisco, Imperial College London, and laboratories affiliated with Institut Pasteur and Robert Koch Institute expanded on streptomycin resistance mechanisms and combination chemotherapy. Work by researchers associated with Albert Einstein College of Medicine, UCLA, McGill University, and Karolinska Institute advanced multi-drug regimens and informed modern guidelines from organizations such as the World Health Organization and Centers for Disease Control and Prevention. The trial's methodological and ethical lessons influenced evolution of clinical trial governance at institutions like National Institutes of Health and inspired subsequent randomized controlled trials at hospitals such as Guy's Hospital, St Thomas' Hospital, and King's College Hospital.
Category:Clinical trials Category:Tuberculosis Category:Antibiotics